The Invisible Erosion: Identifying the Silent Quality Killers of Clinical Trial Success<br><span style="font-size: 20px;">Part 1 of a 3-part series</span>
Reading Time: 2 minutesIn the high-stakes environment of clinical drug development, the most dangerous risks are rarely the ones that fail loudly. We are conditioned to fear the catastrophic, headline-grabbing failures—the sudden suspension of a trial due to a major safety event or a sudden regulatory hold. Yet, the reality of clinical operations is far more subtle. The […]
Article
